Molecular Disease
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas. (NCT03115138) | Centre Hospitalier Universitaire, Amiens | 2016-03-09 |
Track Molecular Disease automatically
Every clearance here is in the API, with alerts when new ones post.